Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


esther.becker@dpag.ox.ac.uk

Social media

Esther Becker

PhD MSc

Visiting Professor of Translational Neuroscience

Esther graduated from the University of Amsterdam cum laude with a MSc degree in Medical Biology in 2000.  She then joined the Biomedical and Biological Sciences program at Harvard University, where she performed her PhD training with Azad Bonni. Her work as a graduate student has made significant contributions to our understanding of the specific signaling mechanisms that regulate cell death in the nervous system, particularly in the developing cerebellum. For her graduate studies, Esther was awarded a PhD Fellowship from the Boehringer Ingelheim Fonds and an Albert J. Ryan Foundation Fellowship.

After completing her PhD in 2006, Esther joined Kay Davies’ group in DPAG having been awarded a Human Frontier Science Program Fellowship and later an OXION Training Fellowship. In 2010, Esther was awarded a prestigious Dorothy Hodgkin Research Fellowship from the Royal Society to establish her own research programme, focussing on the genetic and molecular underpinnings of cerebellar ataxia in mice and humans. Esther joined the faculty of the Nuffield Department of Clinical Neuosciences in 2020 and is a member of the Kavli Institute for Nanoscience Discovery. She is also Co-Director of the Oxford Interdisciplinary Bioscience  Doctoral Training Partnership and Vice President and Official Fellow at Reuben College.

The Becker group aims to understand the genetic, molecular and cellular mechanisms that underlie neurodevelopmental and neurodegenerative diseases of the cerebellum with the ultimate aim of developing better treatments for these disorders.

Key publications

Recent publications

More publications